APP下载

TACE联合氟尿嘧啶植入剂治疗不可切除的中晚期肝癌患者30例疗效观察

2015-09-08蒋水明等

右江医学 2015年4期
关键词:原发性肝癌

蒋水明等

【摘要】目的探讨肝动脉化疗栓塞术(transarterial chemoembolization,TACE)联合氟尿嘧啶植入剂治疗中晚期肝癌的临床疗效。方法选取2010年1月至2013年6月行TACE联合氟尿嘧啶植入剂治疗的30例中晚期肝癌患者,术后定期随访,监测肝功能、血清AFP变化,按照RECIST标准每4~6周对患者进行疗效评价,定期行彩超及增强螺旋CT检查,判定肿瘤治疗效果。结果30例患者均顺利完成TACE联合氟尿嘧啶植入剂治疗,术后无肝内血肿、脓肿等严重并发症。治疗后2个月部分缓解8例,病情稳定20例,总有效率为26.67%(8/30)。患者术前、术后1年、术后2年的Childpugh评分为差异无统计学意义(P>0.05)。患者术后中位生存时间为27.9个月,术后1、2、3年累积生存率分别为97%、69%、25%。结论TACE联合氟尿嘧啶植入剂治疗中晚期肝癌是安全可行的,可提高肿瘤缓解率、患者生存率,是安全有效的姑息性治疗方法。

【关键词】原发性肝癌;肝动脉化疗栓塞术;氟尿嘧啶植入剂

中图分类号:R735.7 文献标识码:ADOI:10.3969/j.issn.10031383.2015.04.005

【Abstract】ObjectiveTo investigate the clinical efficacy of transarterial chemoembolization (TACE) combined with fluorouracil implants in intermediate or advanced liver cancer.Methods30 intermediate or advanced liver cancer patients who had received the treatment of TACE combined with fluorouracil implants during the period of January,2010 to June,2013 were selected as study objects.After the operation,a followup visit was conducted regularly to monitor liver function and AFP serum changes.Every four to six weeks,efficacy evaluation was carried on according to RECIST standard.In addition,color Doppler ultrasound and enhanced spiral CT scan were conducted regularly to evaluate the tumor treatment effect.Results All patients finished the treatment of TACE combined with fluorouracil implants without serious postoperative complications such as intrahepatic hematoma and abscess.Two months after the treatment,partial remission and stable disease were respectively obtained in 8 cases and 20 cases,and total effective rate was 26.67%(8/30).Difference of ChildPugh scores before the operation,one year and two years after the operation was not statistically significant (P>0.05).Middle survival time of the patients was 27.9 months,and the cumulative survival rate of one year,two and three years after the operation were 97%,69% and 25%,respectively.ConclusionTACE combined with fluorouracil implants is safe and viable in the treatment of intermediate or advanced liver cancer,and it is also a safe and effective palliative therapy in increasing the tumor remission rate and the survival rate.

【Key words】primary liver cancer;TAEC;fluorouracil implants

肝动脉化疗栓塞术(transarterial chemoembolization,TACE)为无法手术切除的中晚期肝癌的首选方法,但由于肝癌具有双重血供,中心主要由肝动脉供血,周边主要由门静脉供血,且部分肝癌还存在肝外动脉供血,致使TACE难以完全中断肿瘤血供,导致术后完全坏死率低。此外,TACE后血管内皮生长因子(VEGF)表达上调,促进肿瘤血管新生,导致肝动脉被阻断后不久侧支循环迅速建立,致使TACE短期能取得较好的疗效,但多次、远期疗效并不理想。近年来氟尿嘧啶植入剂广泛应用于胃肠道肿瘤治疗。这种新型药物植入瘤组织后表面速释层迅速释放抗癌药,于短时间内使药物作用于整个瘤体,达到有效抑制肿瘤浓度,而缓释部分持续释放形成长时间的有效浓度杀灭肿瘤细胞。本……

登录APP查看全文

猜你喜欢

原发性肝癌
三维适形半野轮照放疗技术治疗局部晚期原发性肝癌的临床疗效
消癌平片联合TACE术治疗老年原发性肝癌的疗效和生命质量的临床观察
贝伐单抗联合肝动脉化疗栓塞术对36例晚期原发性肝癌生存预后的影响分析
TACE序贯3D—CRT治疗原发性肝癌的疗效及安全性观察
探析介入治疗中晚期原发性肝癌破裂出血的安全性观察
不同血流阻断法在原发性肝癌手术中的效果分析
超声造影在腹腔镜射频消融治疗原发性肝癌中的效果
GP73、AFP 异质体联合检测在原发性肝癌早期诊断中的应用进展
腹腔镜肝切除治疗原发性肝癌的疗效观察
介入治疗在原发性肝癌中的应用